Thursday, November 19, 2026 Vol. I · No. 7
Business · Via CNBC

Novartis raises blockbuster drug forecasts to $18 billion as it seeks to prove growth can last

The drugmaker cited strong demand for its blockbuster drugs as it upgraded peak sales forecasts for multiple sclerosis, leukemia, and cholesterol medicines.

This is a brief. The reporting belongs to CNBC — read the complete story, with full context and credits, at the source.

Read the full story at CNBC ↗

cnbc.com

More from the Business desk